2Kim EJ, Lee RK, Lee SM, et al. General pharmacology of IY-81149, a new proton pump inhibitor. Arzneimittelforschung, 2001, 51:51-59.
3Kwon D, Chae JB, Park CW, et al. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Arzneimittelforsehurg, 2001, 51:204-213.
4Klok RM, Postma MJ, van Hour BA, et al. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Aliment PharmacoI Ther, 2003, 17 : 1237-1245.
5Kim EJ, Lee RK, Kim DY, et al. General pharmacology of IY- S1149: a new proton pump inhibitor. Arzneiminelforschung, 2001,51:51-59.
6Kwon D, Chae JB, Park CW, et al. Effects of IY-81149:a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Arzneimittelforschung, 2001,51:204-213.
7Goldwater R, Boileau F, Lee SM, et al. A phase Ⅰ randomized, parallel, placebo-controlled, safety, tolerance and pharmacokinetie study of single ascending doses of IY-81149 in fasting male volunteers. Clinical Pharmacology & Therapeutics, 1999, 65 : 126.
8Sakai T, Aoyama N, Kita T, et al. CYP2C19 genotype and pharmacokinetics of three proton pmp inhibitors in healthy subj ects. Pharm Res, 2001, 18:721-727.
9Klok RM,Postma M J, van Hout BA,et al. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Aliment Pharmacol Ther, 2003, 17:1237-1245.
1Kwon D,Chae JB,Park CW,et al.Effects of a newly developed proton pump inhibitor,on gastric acid secretion in vitro and in vivo.Arzneimittelforschung,2001,51 (3):204.
2Ho KY,Kuan A,Zaìo F,et al.Randomized,parallel,doubleblindcomparison of the ulcer-healing effects ofilaprazole and omeprazole in the treatment of gastric andduodenal ulcers.J Gastroentero1,2009,44(7):697.
